EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 3.0

Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study

Bing-Wei Lu, Can Zhao, Da-Zhong Wang, Wei Wang

Drug Design, Development and Therapy · 2026-05 · Volume 20 · 1-16

DOI: 10.2147/dddt.s608659 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Drug Design, Development and Therapy, 2026-05. Verfasst von Bing-Wei Lu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of general Medicine, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian…. Hauptthemen laut MEDLINE: Indoles, Quinolines, Lung Neoplasms, Small Cell Lung Carcinoma. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndolesQuinolinesLung NeoplasmsSmall Cell Lung CarcinomaImmune Checkpoint InhibitorsAntineoplastic Combined Chemotherapy ProtocolsAntineoplastic AgentsHumansAgedFemaleRetrospective StudiesMaleAged, 80 and overNeoplasm Staging

Stichwörter der Autor:innen

anlotinibchemotherapyeffectivenesselderlyextensive-stage small-cell lung cancerimmune checkpoint inhibitorssafety

Substanzen

anlotinibIndolesQuinolinesImmune Checkpoint InhibitorsAntineoplastic Agents

Autor:innen und Institutionen

  • Department of general Medicine, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, People's Republic of Ch…
  • Department of Cardiothoracic Surgery, General Hospital of Fushun Mining Bureau of Liaoning Health Industry Group, Fushun, Liaoning, People's Republic of China.
  • Department of Pulmonology, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, People's Republic of China.
  • Department of Thoracic surgery, Liaoning Cancer Hospital & Institute, Cancer Hospital of China Medical University, Liaoning Cancer Hospital of Dalian University of Technology, Shenyang, Liaoning, People's Republic of Ch…

Zitieren

APA

Lu, B. W., Zhao, C., Wang, D. Z., & Wang, W. (2026). Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study. Drug Design, Development and Therapy, Volume 20, 1-16. https://doi.org/10.2147/dddt.s608659

Vancouver

Lu BW, Zhao C, Wang DZ, Wang W. Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study. Drug Design, Development and Therapy. 2026;Volume 20:1-16. doi:10.2147/dddt.s608659

BibTeX
@article{Lu2026,
  author = {Lu, Bing-Wei and Zhao, Can and Wang, Da-Zhong and Wang, Wei},
  title = {Anlotinib Plus Immune Checkpoint Inhibitors versus Chemotherapy in Elderly Patients with Extensive-Stage Small-Cell Lung Cancer: A Real World, Exploratory Study},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  volume = {Volume 20},
  pages = {1--16},
  doi = {10.2147/dddt.s608659}
}
Kostenlos starten →